This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday – Apellis Pharmaceuticals (NASDAQ:APLS), Abivax (NASDAQ:ABVX)

Nov 6, 2025
this-brinker-international-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-thursday-–-apellis-pharmaceuticals-(nasdaq:apls),-abivax-(nasdaq:abvx)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst James Faucette initiated coverage on Galaxy Digital Inc (NASDAQ:GLXY) with an Overweight rating and announced a price target of $42. Galaxy Digital shares closed at $31.44 on Wednesday. See how other analysts view this stock.
  • Freedom Capital Markets analyst Lynne Collier initiated coverage on Brinker International Inc (NYSE:EAT) with a Buy rating and announced a price target of $145. Brinker shares closed at $103.52 on Wednesday. See how other analysts view this stock.
  • Wolfe Research analyst Steve Fleishman initiated coverage on Abivax SA (NASDAQ:ABVX) with an Outperform rating and announced a price target of $176. Abivax shares closed at $99.61 on Wednesday. See how other analysts view this stock.
  • Freedom Capital Markets analyst Lynne Collier initiated coverage on BJ’s Restaurants Inc (NASDAQ:BJRI) with a Buy rating and announced a price target of $44. BJ’s Restaurants closed at $35.79 on Wednesday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen initiated coverage on Apellis Pharmaceuticals Inc (NASDAQ:APLS) with a Peer Perform rating. Apellis Pharmaceuticals shares closed at $19.95 on Wednesday. See how other analysts view this stock.

Considering buying EAT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment